PRP hair treatment in Kochi,
double-spin, leukocyte-poor, dermatologist-injected.

The IADVL 2024 consensus specifies a minimum platelet concentration of 1×10⁶ platelets/µL (4-7× the patient's baseline) for therapeutic efficacy in androgenetic alopecia. Concentrations below this are sub-clinical, a common reason PRP fails to produce results in patients who report no improvement after multiple sessions elsewhere. The standard protocol is monthly injection × 3-5 sessions, followed by maintenance every 4-6 months. Response is visible at month 3 and peaks at month 6 (IDOJ 2021).

PRP isolates the entire platelet layer from your blood (single-spin centrifugation), including the platelets, plasma, and some white blood cells. GFC is more refined: a double-spin protocol removes the red and white blood cells, leaving only purified growth factors. A 2024 comparative study in the Journal of Dermatological Case Reports found GFC yielded 28.6 hairs/cm² versus PRP's 19.2, 49% superior density gain. GFC is also less painful (no RBC/WBC inflammatory burden). DermaVue Kochi offers both; GFC is preferred when budget allows.

PRP/GFC injection alone is meaningfully less effective than the combined protocol (injection + topical minoxidil + oral finasteride in eligible men). Androgenetic alopecia is hormone-driven (dihydrotestosterone shrinks follicles); without blocking that pathway, injection-induced regrowth is competing against ongoing hormonal miniaturisation. The IADVL recommendation is combined protocol for best response. Finasteride is for men only; female AGA uses spironolactone (where indicated) or topical anti-androgens.

The commonly cited sexual side effects (reduced libido, erectile dysfunction, ejaculatory volume reduction) affect 1-2% of users in randomised trial data, significantly less than the 5-10% sometimes quoted. Most are reversible on discontinuation. Patients with concerns can do a 6-month trial with formal libido / erectile function tracking before committing long-term. Topical finasteride is an alternative with similar efficacy and reduced systemic exposure.

PRP standard: 3-5 monthly sessions for initial response, then maintenance every 4-6 months. GFC standard: 3-4 sessions at 4-6 week intervals. Trichoscopy at month 3 confirms response; the full assessment is at month 6 (peak follicular density gain). Maintenance frequency depends on response pattern and patient compliance with topical / oral therapy.

PRP/GFC works for female pattern hair loss (Ludwig I-III), but the workup matters more in female patients. Many female hair-loss cases are not androgenetic but rather nutritional (low ferritin, low vitamin D), thyroid (under- or overactive), autoimmune (alopecia areata, lupus-related), or post-partum / post-COVID telogen effluvium. The 6-blood panel before injection therapy catches these, injecting growth factors into a non-AGA scalp wastes patient money. Dr. Minu Liz Mathew leads the female-hair-loss workup at DermaVue Kochi.

Surgical FUE hair transplant becomes the rational choice when (a) hair loss is established at Norwood III or beyond in men, or (b) medical therapy plateaus after 12-18 months of compliance, or (c) the patient has clear focal areas of loss with healthy donor zone density. Dr. Johna PS (MDS, FUE specialist) at DermaVue Kochi performs the surgical procedure using Korean Choi implanter pen technology, 92-96% graft survival. The medical hair-loss programme and surgical programme are coordinated, with referral pathway built in.

The standard 6-blood panel at first consultation: serum ferritin (iron stores), 25(OH) vitamin D, TSH + free T3 + free T4 (thyroid), ANA (antinuclear antibody screen for autoimmune cause), fasting insulin + HbA1c (PCOS / insulin resistance, particularly relevant in female patients). Total cost typically ₹2,500-4,500 at standard labs. Many hair-loss cases turn out to have a correctable nutritional or hormonal driver, a critical step often skipped at non-dermatologist 'hair clinics'.

PRP at DermaVue Kochi is ₹3,500-12,000 per session, pricing depends on preparation method (single-spin vs double-spin, IADVL-spec platelet concentration verification). A standard 3-5 session course is ₹15,000-45,000 total. GFC is ₹6,000-15,000 per session, with a 3-4 session course at ₹20,000-45,000. Maintenance is one session every 4-6 months thereafter. Topical minoxidil and oral finasteride add ₹1,500-3,000 per quarter. Combined year programme (injection + topical + oral) ₹35,000-80,000.

Yes, this is the IADVL-recommended combined protocol. Topical minoxidil 5% (men) or 2% (women) daily prolongs anagen phase and enlarges miniaturised follicles; PRP/GFC stimulates the same follicles via growth factor delivery; oral finasteride (men) blocks the hormonal driver of miniaturisation. The three mechanisms compound, combined protocol response significantly exceeds monotherapy. DermaVue's standard programme is all three from month 1.